LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article: A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML.

    Jonas, Brian A / Potter, Laura A / Galkin, Maria / Tuscano, Joseph M

    Leukemia research reports

    2023  Volume 19, Page(s) 100374

    Language English
    Publishing date 2023-06-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 2706248-X
    ISSN 2213-0489
    ISSN 2213-0489
    DOI 10.1016/j.lrr.2023.100374
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article: Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy.

    Galkin, Maria / Jonas, Brian A

    Core evidence

    2019  Volume 14, Page(s) 3–17

    Abstract: Introduction: ...

    Abstract Introduction:
    Language English
    Publishing date 2019-04-26
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2520695-3
    ISSN 1555-175X ; 1555-1741
    ISSN (online) 1555-175X
    ISSN 1555-1741
    DOI 10.2147/CE.S172912
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Diagnostic Dilemma: Carcinoid Syndrome.

    Beri, Neil / Farid, Amir / Galkin, Maria / Lewis, William / Amsterdam, Ezra

    The American journal of medicine

    2018  Volume 131, Issue 10, Page(s) e405–e407

    MeSH term(s) Aged ; Carcinoid Heart Disease/diagnosis ; Carcinoid Heart Disease/physiopathology ; Carcinoid Heart Disease/therapy ; Diagnosis, Differential ; Echocardiography/methods ; Female ; Humans ; Patient Care Management/methods ; Prognosis ; Stroke Volume ; Tricuspid Valve/diagnostic imaging ; Tricuspid Valve/pathology ; Tricuspid Valve Insufficiency/diagnosis ; Tricuspid Valve Insufficiency/etiology ; Tricuspid Valve Insufficiency/physiopathology
    Language English
    Publishing date 2018-06-12
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 80015-6
    ISSN 1555-7162 ; 1873-2178 ; 0002-9343 ; 1548-2766
    ISSN (online) 1555-7162 ; 1873-2178
    ISSN 0002-9343 ; 1548-2766
    DOI 10.1016/j.amjmed.2018.05.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ua VI Zs.289: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Breast cancer-specific survival in patients with HER2-positive, node-negative T1a and T1b breast cancer.

    Parikh, Mamta / Galkin, Maria / Brunson, Ann / Keegan, Theresa / Chew, Helen K

    Cancer treatment and research communications

    2018  Volume 16, Page(s) 38–44

    Abstract: Purpose: There is limited data on prognosis of node-negative (N0), HER2-positive (HER2+) small breast cancers. We evaluated breast cancer-specific survival (BCSS) among women diagnosed with T1a/T1b, N0 tumors in California between 2000-2004 and 2005- ... ...

    Abstract Purpose: There is limited data on prognosis of node-negative (N0), HER2-positive (HER2+) small breast cancers. We evaluated breast cancer-specific survival (BCSS) among women diagnosed with T1a/T1b, N0 tumors in California between 2000-2004 and 2005-2012, eras before and after approval of adjuvant trastuzumab.
    Patients and methods: 45,346 women diagnosed with T1a/b, N0 tumors between January 1, 2000 and December 31, 2012 were identified in the California Cancer Registry (CCR); approximately 10% were HER2 + , and 80% hormone receptor positive (ER and/or PR+). Primary outcome was BCSS, analyzed in 2000-2004 and 2005-2012. Multivariable Cox proportional hazards regression was used to calculate hazard ratios and 95% confidence intervals for mortality, and separately conducted for hormone receptor positive and negative tumors. Kaplan-Meier curves compared BCSS by HER2 status.
    Results: While BCSS in this cohort exceeded 90%, a significantly higher hazard of breast cancer death was observed in women with HER2+ tumors in the 2000-2004 era. There was no difference in outcomes between T1a and T1b tumors. Women with ER/PR+ tumors had lower hazards of death in both eras, but HER2+ tumors were associated with a higher hazard of death in the 2000-2004 era. Among women with hormone receptor negative tumors, HER2 positive disease was associated with a lower hazard of death in the 2005-2012 era.
    Conclusion: Within this large cohort of T1a/b N0 breast cancers from the CCR, HER2+ tumors were associated with a significantly worse BCSS in the era before adjuvant trastuzumab. A balanced discussion regarding HER2-directed therapies is needed between patient and clinician.
    Language English
    Publishing date 2018-06-13
    Publishing country England
    Document type Journal Article
    ISSN 2468-2942
    ISSN (online) 2468-2942
    DOI 10.1016/j.ctarc.2018.06.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top